Financials

  • Market Capitalization 39.1071 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.16
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
6416
ADAP
Adaptimmune Therapeutics plc - American Depositary Shares
0.05 USD0.00%0.00%-61.54%-83.33%0 USD
6419
AADI
Aadi Bioscience Inc
2.05 USD0.00%0.00%-19.29%-27.30%0 USD
6747
NAMSW
NewAmsterdam Pharma Company N.V. - Warrant
24.8900 USD0.00%+8.45%+32.46%+169.66%3.97 B USD
6877
DRTSW
Alpha Tau Medical Ltd. - Warrant
3.2559 USD-11.04%-10.80%+55.04%+1062.82%1.07 B USD